Your browser doesn't support javascript.
loading
[Requirements for a cross-location biobank IT infrastructure : Survey of stakeholder input on the establishment of a biobank network of the German Biobank Alliance (GBA)]. / Anforderungen an eine standortübergreifende Biobanken-IT-Infrastruktur : Erhebung des Stakeholderinputs zum Aufbau eines Biobankennetzwerks der German Biobank Alliance (GBA).
Schüttler, C; Buschhüter, N; Döllinger, C; Ebert, L; Hummel, M; Linde, J; Prokosch, H-U; Proynova, R; Lablans, M.
Afiliação
  • Schüttler C; Lehrstuhl für Medizinische Informatik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Wetterkreuz 13, 91058, Erlangen, Deutschland. christina.schuettler@fau.de.
  • Buschhüter N; Zentralisierte Biomaterialbank der Medizinischen Fakultät der RWTH Aachen University, Aachen, Deutschland.
  • Döllinger C; BioMaterialBank Heidelberg, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
  • Ebert L; Medizinische Informatik in der Translationalen Onkologie, Deutsches Krebsforschungszentrum, Heidelberg, Deutschland.
  • Hummel M; Zentrale Biomaterialbank (ZeBanC) und German Biobank Node (GBN), Charité-Universitätsmedizin Berlin, Berlin, Deutschland.
  • Linde J; UMG Biobank, Universitätsmedizin Göttingen, Göttingen, Deutschland.
  • Prokosch HU; Lehrstuhl für Medizinische Informatik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Wetterkreuz 13, 91058, Erlangen, Deutschland.
  • Proynova R; Medizinische Informatik in der Translationalen Onkologie, Deutsches Krebsforschungszentrum, Heidelberg, Deutschland.
  • Lablans M; Medizinische Informatik in der Translationalen Onkologie, Deutsches Krebsforschungszentrum, Heidelberg, Deutschland.
Pathologe ; 39(4): 289-296, 2018 Jul.
Article em De | MEDLINE | ID: mdl-29691676
ABSTRACT

BACKGROUND:

The large number of biobanks within Germany results in a high degree of heterogeneity with regard to the IT components used at the respective locations. Within the German Biobank Alliance (GBA), 13 biobanks implement harmonized processes for the provision of biomaterial and accompanying data.

OBJECTIVES:

The networking of the individual biobanks and the associated harmonisation of the IT infrastructure should facilitate access to biomaterial and related clinical data.

METHODS:

For this purpose, the relevant target groups were first identified in order to determine their requirements for IT solutions to be developed in a workshop.

RESULTS:

Of the seven identified interest groups, three were initially invited to a first round of discussions. The stakeholder input expressed resulted in a catalogue of requirements with regard to IT support for (i) a sample and data request, (ii) the handling of patient consent and inclusion, and (iii) the subsequent evaluation of the sample and data request.

CONCLUSIONS:

The next step is to design the IT solutions as prototypes based on these requirements. In parallel, further user groups are being surveyed in order to be able to further concretise the specifications for development.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bancos de Espécimes Biológicos Limite: Humans País/Região como assunto: Europa Idioma: De Revista: Pathologe Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bancos de Espécimes Biológicos Limite: Humans País/Região como assunto: Europa Idioma: De Revista: Pathologe Ano de publicação: 2018 Tipo de documento: Article